ResMed (RMD) Reports In-Line Q3 EPS
Get Alerts RMD Hot Sheet
Price: $198.03 +0.87%
EPS Growth %: +14.9%
Financial Fact:
Research and development: 34.45M
Today's EPS Names:
SHIM, KOD, HEWA, More
EPS Growth %: +14.9%
Financial Fact:
Research and development: 34.45M
Today's EPS Names:
SHIM, KOD, HEWA, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q3 EPS of $0.65, in-line with the analyst estimate of $0.65. Revenue for the quarter came in at $422.5 million versus the consensus estimate of $425.76 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Midday movers: RH, Estee Lauder rise; Tesla falls
- NaaS Technology Inc. (NAAS) Reports Q1 Loss of $0.29
- Pineapple Energy Inc. (PEGY) Misses Q4 EPS by 8c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!